Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 827, pseudogene (RN7SL827P) is a human pseudogene derived from the 7SL RNA gene, part of the signal recognition particle (SRP) RNA family[1][2][3]. As a pseudogene, RN7SL827P is a non-coding segment of DNA that closely resembles the functional 7SL RNA gene but is generally nonfunctional in terms of producing a stable or biologically active RNA product[2][6]. While most 7SL-derived pseudogenes do not yield functional RNA, some pseudogene transcripts can have regulatory roles, such as acting as microRNA (miRNA) decoys or being processed into small interfering RNAs (siRNAs) that modulate expression of other genes through RNA interference[4]. However, there is no evidence that RN7SL827P functions as a therapeutic target, nor are there reports of drug interactions or use as a biomarker. Its role, if any, would likely be confined to potential regulation of gene expression at the RNA level within specific contexts, but this is not established for this particular pseudogene[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 827, pseudogene (RN7SL827P).